Exagen inc. expands in-network access with evolutions healthcare systems

San diego, march 30, 2022 (globe newswire) -- exagen inc. (nasdaq: xgn), a leading provider of autoimmune testing solutions, announced today that avise® tests have entered into an in-network agreement with evolutions healthcare systems offering access to enhanced care to participating members. the agreement includes exagen's avise® lupus and avise® ctd tests making avise diagnostic testing available as an in-network benefit.
XGN Ratings Summary
XGN Quant Ranking